Effect of riluzole on the neurological and neuropathological changes in an animal model of cardiac arrest-induced movement disorder

Journal of Pharmacology and Experimental Therapeutics

Volumn 288, Issue 3, 1999, Pages 1340-1348

  Kanthasamy, Anumantha G ^a,b,c   Richard J, Yun ^a,b   Nguyen, Bang ^a,b   Truong, Daniel D ^a,b  

^a LONG BEACH MEMORIAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; GLUTAMIC ACID; NEUROPROTECTIVE AGENT; RILUZOLE; SODIUM ION;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT THERAPY; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DOSE RESPONSE; HEART ARREST; HISTOPATHOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MYOCLONUS SEIZURE; NERVE CELL EXCITABILITY; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SODIUM TRANSPORT;

ANIMALS; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; HEART ARREST; HISTOCYTOCHEMISTRY; MALE; MOVEMENT DISORDERS; MYOCLONUS; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; PURKINJE CELLS; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; RILUZOLE;

EID: 0345086408     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. + channels in myelinated nerve fibre. Pfluegers Arch 419:603-609.
2. Boast CA, Gerhardt SC, Pastor G, Lehmann J, Etienne PE and Liebeman JM (1988) The N-Methyl-D-Aspartate antagonists CGS 19755 and CPP reduce ischemic brain damage in gerbils. Brain Res 442:345-348.
3. Butcher SP, Bullock R, Graham DI and McCulloch J (1990) Correlation between amino acid release and neuropathologic outcome in rat brain following middle cerebral artery occlusion. Stroke 21:1727-1733.
4. Carter AJ (1994) Many agents that antagonize the NMDA receptor-channel complex in vivo also causes disturbances of motor coordination. J Pharmacol Exp Ther 269:573-580.
5. Cheramy A, Barbeito L, Godeheu G and Glowinski, J (1992) Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo. Neurosci Lett 147:209-212.
6. Cheung H, Kamp D and Harris E (1992) An in vitro investigation of the action of lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action. Epilepsy Res 13:107-112.
7. Choi DW and Rothman SM (1990) The role of glutamate neurotoxicity in hypoxicischemic neuronal death. Annu Rev Neurosci 13:171-182.
8. Dessi F, Ben-Ari Y and Charriaut-Marlangue C (1993), Riluzole prevents anoxic injury in cultured cerebellar granule neurons. Eur J Pharmacol 250:325-328.
9. Doble A (1996) The pharmacology and mechanism of action of riluzole. Neurology 47:8233-8241.
10. Estevez AG, Stutzmann JM and Barbeito L (1995) Protective effect of riluzole on excitatory amino acid-mediated neurotoxicity in motor neuron-enriched cultures. Eur J Pharmacol 280:47-53.
11. Faden AI, Demediuk P, Panter SS and Vink R (1989) The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science (Wash DC) 244:789-800.
12. Fahn S (1986) Posthypoxic action myoclonus: Literature review and uptake. Adv Neurol 26:49-84.
13. Freyaldenhoven TE, Ali SF and Schmued LC (1997) Systemic administration of MPTP induces thalamic neuronal degeneration in mice. Brain Res 759:9-17.
14. Garthwaite J and Meldrum BS (1990) Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci 11:379-387.
15. Globus M-T, Busto R, Martinez E, Valdes I, Dietrich WD and Ginsberg, MD (1991) Comparative effect of transient global ischemia on extracellular levels of glutamate, glycine, and gamma-aminobutyric acid in vulnerable brain regions in the rat. J Neurochem 57:470-478.
16. Guyton AC (1991) The cerebellum, the basal ganglia, and overall motor control, in Basic Neuroscience-Anatomy & Physiology (Guyton AC ed) 2nd ed., pp 224-253, W.B. Saunders Company, Philadelphia.
17. Hallett M (1987) The pathophysiology of myoclonus. Trends Neurosci 10:69-73
18. Herbert T, Drapeau P, Pradier L and Dunn RJ (1994) Block of the rat brain IIA sodium channel alpha subunit by the neuroprotective drug riluzole. Mol Pharmacol 45:1055-1060.
19. Hubert JP, Delumeau JC, Glowinski, J, Permont J and Doble A (1994) Antagonism by riluzole of entry of calcium evoked by NMDA and veratridine in rat cultured granule cells: Evidence for a dual mechanism of action. Br J Pharmacol 113:261-267.
20. Jaw SP, Hussong MJ, Matsumoto RR and Truong DD (1994) Involvement of 5-HT2 receptors in posthypoxic stimulus-sensitive myoclonus in rats. Pharmacol Biochem Behav 49:129-131.
21. Kanthasamy AG, Matsumoto RR and Truong DD (1996a) Animal models of myoclonus. Clin Neurosci 3:236-245.
22. Kanthasamy AG, Vu TQ, Yun RJ and Truong DD (1996b) Antimyoclonic effect of gabapentin in a posthypoxic animal model of myoclonus. Eur J Pharmacol 297: 219-224.
23. Koek W and Colpaert FC (1990) Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: Relationship with phencyclidine-like behavioral effects. J Pharmacol Exp Ther 252:349-357.
24. Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V and for the Amyotrophic Lateral Sclerosis/Riluzole Study Group-II (1996) Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Lancet 347:1425-1431.
25. Leach MJ, Marden CM and Miller AA (1986) Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action. Epilepsia 27:490-437.
26. Leigh PN and Meldrum BS (1996) Excitotoxicity in ALS. Neurology 47:S221-S227
27. Lipton SA and Rosenberg PA (1994) Excitatory ammo acids as a final common pathway for neurological disorders. N Engl J Med 330:613-622.
28. Malgouris C, Bordot F, Daniel M, Pellis F, Rataud J, Uzan A, Blanchard JC and Laduron PM (1989) Riluzole, a novel antiglutamate, prevents memory loss and hippocampal neuronal damage in ischaemic gerbils. J Neurosci 9:3720-3727.
29. Martin D, Thompson MA and Nadler JV (1993) The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1. Eur J Pharmacol 250:473-476.
30. Matsumoto RR, Aziz N and Truong DD (1995a) Association between brain indolamine levels and severity of posthypoxic myoclonus in rats. Pharmacol Biochem Behav 50:533-538.
31. Matsumoto RR, Nguyen DC and Truong DD (1995b) Strychnine-insensitive glycine antagonists attenuate a cardiac arrest-induced movement disorder. Eur J Pharmacol 275:117-123.
32. Pratt J, Rataud J, Bardot F, Roux M, Blanchard JC, Laduron PM and Stutzmann, JM (1992) Neuroprotective actions of riluzole in rodent models of global and focal cerebral ischemia. Neurosci Lett 140:225-230.
33. Schmued LC, Albertson C and Slikker Jr W (1997) Fluoro-jade: A novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res 761:37-46.
34. Taylor CP, Burk SP and Weber ML (1995) Hippocampal slices: Glutamate overflow and cellular damage from ischemia are reduced by sodium channel blockade J Neurosci Methods 59:121-128,
35. + channels as targets for neuroprotective drugs. Trends Pharmacol Sci 16:309-316.
36. Truong DD, Matsumoto RR, Schwartz PH, Hussong MJ and Wasterlain, CG (1994) A novel rat cardiac arrest model of post-hypoxic myoclonus. Mov Disorder 9:201-206.
37. Truong DD, Vu TQ, Matsumoto RR and Kanthasamy AG (1995) Nitric oxide mediated neurological disorder in a posthypoxic rats (Abstract). Neuroscience 21:1379.
38. + channels: A rational and effective strategy against ischemic brain damage. Pharmacol Rev 48:21-67.
39. Wijdicks EFM, Parisi JE and Sharbrough FW (1994) Prognostic value of myoclonus status in comatose survivors of cardiac arrest. Ann Neurol 35:239-243.
40. Xie X, Lancaster B, Peakman T and Garthwaite J (1995) Interaction of the antiepileptic drug lamotrigine with recombinant rat brain type IIA Na channels and with native Na channels in rat hippocampal neurons. Pfluegers Arch Eur J Physiol 430:437-446.